Clinical Research Directory
Browse clinical research sites, groups, and studies.
Performance Evaluation of ANI in Patients Under General Anesthesia With Remimazolam
Sponsor: Catholic Kwandong University
Summary
The purpose of this study is to determine whether Analgesia Nociception Index (ANI) can effectively reduce the dose of opioid in patients who underwent general anesthesia using remimazolam.
Official title: Performance Evaluation of Analgesia Nociception Index (ANI) in Patients Under General Anaesthesia With Remimazolam: a Prospective Observational Study
Key Details
Gender
All
Age Range
20 Years - 79 Years
Study Type
OBSERVATIONAL
Enrollment
30
Start Date
2024-04-23
Completion Date
2025-06-11
Last Updated
2024-05-30
Healthy Volunteers
No
Conditions
Interventions
Analgesia Nociception Index, remimazolam
The purpose of this study is to determine the validity of ANI in patients undergoing surgery with remifentanil and remimazolam. During this study, remimazolam infusion rate is determined by the pharmacopoeia. Remifentanil infusion rate is determined based on the patient's vital signs, systemic status and pain levels. And remifentanil is administrated via targeted infusion control using the Minto model. ANI scores, vital signs, remifentanil infusion rate are collected at predetermined time points according to the protocol from the start to the end of the surgery.
Locations (1)
Catholic-Kwandong University, School of Medicine
Incheon, South Korea